GANCICLOVIR Side Effects

7005475-X | Cytomegalovirus Infection, Headache, Hypertransaminasaemia, Hypogammaglobulinaemia, Leukopenia, Nephropathy Toxic, Pyrexia, Thrombocytopenia, Thrombotic Microangiopathy
on Sep 14, 2010 Male patient from POLAND , 30 years of age, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?), immunosuppression and was treated with Ganciclovir (View Usage). Patient experienced the following unwanted or unexpected effects: cytomegalovirus infection (What is cytomegalovirus infection?), headache (What is headache?), hypertransaminasaemia, hypogammaglobulinaemia, leukopenia, nephropathy toxic, pyrexia, thrombocytopenia, thrombotic microangiopathy. Ganciclovir dosage: Biweekly Dose. During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ). Patient was hospitalized.

6552036-2 | Cerebral Haemorrhage, Cytomegalovirus Infection, Lymphoproliferative Disorder
Patient was taking Ganciclovir (View Usage). Patient had the following side effects: cerebral haemorrhage, cytomegalovirus infection (What is cytomegalovirus infection?), lymphoproliferative disorder on Jan 20, 2010 from JAPAN Additional patient health information: Male patient , 58 years of age, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?), prophylaxis against graft versus host disease and. Ganciclovir dosage: . During the same period patient was treated with CELLCEPT (View Cellcept Review and Cellcept Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), PREDNISOLONE (Given For Acute Gvhd Involving The Skin And Gut On Day 23.) (View Prednisolone Review and Prednisolone Label ), FOSCARNET (View Foscarnet Review and Foscarnet Label ).

6497659-4 | West Nile Viral Infection
Adverse event was reported on Dec 07, 2009 by a Female patient taking Ganciclovir (View Usage) (Dosage: ) was diagnosed with non-hodgkin's lymphoma and. Location: UNITED STATES , 47 years of age, After Ganciclovir was administered, patient had the following side effects: west nile viral infection. During the same period patient was treated with RITUXIMAB (600 Mg; On Day 1;five Monthly Cycles) (View Rituximab Review and Rituximab Label ), FLUDARABINE (40 Mg; For Five Days Every Cycle; Received Five Monthly Cycles) (View Fludarabine Review and Fludarabine Label ), CEFTRIAXONE SODIUM (View Ceftriaxone Sodium Review and Ceftriaxone Sodium Label ), AMPICILLIN (View Ampicillin Review and Ampicillin Label ). Patient was hospitalized.

6492516-1 | Anaphylactic Reaction, Haemorrhagic Stroke, Pulmonary Embolism
on Dec 07, 2009 Male patient from UNITED STATES , 62 years of age, weighting 187.4 lb, was diagnosed with transplant rejection and was treated with Ganciclovir (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, haemorrhagic stroke, pulmonary embolism (What is pulmonary embolism?). Ganciclovir dosage: . During the same period patient was treated with SOLU MEDROL (Oth Indication: Immunosuppression, Form: Powder For Solution For Infusion) (View Solu-medrol Review and Solu-medrol Label ), CYTOGAM (View Cytogam Review and Cytogam Label ), INSULIN (View Insulin Review and Insulin Label ), PROTONIX (View Protonix Review and Protonix Label ).


6483107-7 | Cerebral Haemorrhage, Cytomegalovirus Infection, Epstein-barr Virus Associated Lymphoproliferative Disorder
on Nov 30, 2009 Male patient from JAPAN , 58 years of age, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and was treated with Ganciclovir (View Usage). Patient had the following side effects: cerebral haemorrhage, cytomegalovirus infection (What is cytomegalovirus infection?), epstein-barr virus associated lymphoproliferative disorder. Ganciclovir dosage: . During the same period patient was treated with MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), PREDNISOLONE (Given For Acute Gvhd Involving The Skin And Gut On Day 23.) (View Prednisolone Review and Prednisolone Label ), FOSCARNET (View Foscarnet Review and Foscarnet Label ).

6441093-X | Cytomegalovirus Enterocolitis, Gastrointestinal Haemorrhage, Hypoaesthesia, Loss Of Consciousness, Respiratory Failure, Shock Haemorrhagic
Patient was taking Ganciclovir (View Usage). After Ganciclovir was administered, patient had the following side effects: cytomegalovirus enterocolitis, gastrointestinal haemorrhage, hypoaesthesia, loss of consciousness, respiratory failure, shock haemorrhagic on Nov 09, 2009 from JAPAN Additional patient health information: Male patient , 74 years of age, . Ganciclovir dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

6399712-2 | Pneumonia Cytomegaloviral
Adverse event was reported on Oct 05, 2009 by a Male patient taking Ganciclovir (View Usage) (Dosage: ) was diagnosed with lymphoma (What is lymphoma?), diffuse large b-cell lymphoma and. Location: UNITED STATES , 57 years of age, Patient experienced the following unwanted or unexpected effects: pneumonia cytomegaloviral. During the same period patient was treated with MABTHERA (View Mabthera Review and Mabthera Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ).

6368303-1 | Autoimmune Thrombocytopenia, Cytomegalovirus Infection
on Sep 14, 2009 Male patient from UNITED STATES , 50 years of age, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?), idiopathic thrombocytopenic purpura and was treated with Ganciclovir (View Usage). Patient had the following side effects: autoimmune thrombocytopenia, cytomegalovirus infection (What is cytomegalovirus infection?). Ganciclovir dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), IMMUNE GLOBULIN INTRAVENOUS (HUMAN) (View Immune Globulin Intravenous (human) Review and Immune Globulin Intravenous (human) Label ), ANTI D IMMUNOGLOBULIN (Combination Treatment) (View Anti-d Immunoglobulin Review and Anti-d Immunoglobulin Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ).

6334644-7 | Acinetobacter Infection, Candiduria, Cytomegalovirus Enteritis, Renal Failure, Respiratory Failure, Staphylococcal Infection
on Aug 26, 2009 Male patient from PORTUGAL , 66 years of age, was treated with Ganciclovir (View Usage). After Ganciclovir was administered, patient had the following side effects: acinetobacter infection, candiduria, cytomegalovirus enteritis, renal failure, respiratory failure, staphylococcal infection (What is staphylococcal infection?). Ganciclovir dosage: . During the same period patient was treated with GLIBENCLAMIDE (View Glibenclamide Review and Glibenclamide Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6332628-6 | Cytomegalovirus Enteritis
Patient was taking Ganciclovir (View Usage). Patient experienced the following unwanted or unexpected effects: cytomegalovirus enteritis on Aug 24, 2009 from PORTUGAL Additional patient health information: Male patient , 66 years of age, . Ganciclovir dosage: .

6309416-X | Cytomegalovirus Infection, Human Herpesvirus 6 Infection, Lung Infection Pseudomonal, Neutropenia
Adverse event was reported on Aug 10, 2009 by a Male patient taking Ganciclovir (View Usage) (Dosage: ) was diagnosed with prophylaxis against transplant rejection and. Location: ITALY , 43 years of age, Patient had the following side effects: cytomegalovirus infection (What is cytomegalovirus infection?), human herpesvirus 6 infection, lung infection pseudomonal, neutropenia. During the same period patient was treated with FOSCARNET (View Foscarnet Review and Foscarnet Label ), ALEMTUZUMAB (Before Transplant After Reperfusion At Day 3 And At Day 7.) (View Alemtuzumab Review and Alemtuzumab Label ), TACROLIMUS (Torugh Blood Level Of 10-15 Ng/ml During The First Three Months Followed By 8-12 Ng/ml, Thereafter.) (View Tacrolimus Review and Tacrolimus Label ).

6307475-1 | Acute Graft Versus Host Disease In Skin, Bk Virus Infection, Cytomegalovirus Viraemia, Dyspnoea, Gastrointestinal Disorder, Respiratory Distress, Respiratory Failure, Respiratory Tract Infection Fungal
on Aug 04, 2009 Male patient from UNITED STATES , 63 years of age, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?), b-cell lymphoma refractory, infection prophylaxis, graft versus host disease and was treated with Ganciclovir (View Usage). After Ganciclovir was administered, patient had the following side effects: acute graft versus host disease in skin, bk virus infection, cytomegalovirus viraemia, dyspnoea, gastrointestinal disorder, respiratory distress, respiratory failure, respiratory tract infection fungal. Ganciclovir dosage: . During the same period patient was treated with FOSCARNET (View Foscarnet Review and Foscarnet Label ), BUSULFAN (View Busulfan Review and Busulfan Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), ALEMTUZUMAB (Total Dose: 60 Mg.v.) (View Alemtuzumab Review and Alemtuzumab Label ), POSACONAZOLE (With Food.) (View Posaconazole Review and Posaconazole Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ). Patient was hospitalized.

6246800-7 | Bronchospasm, Dyspnoea, Wheezing
on Jun 24, 2009 Female patient from UNITED STATES , 26 years of age, was diagnosed with antiviral prophylaxis and was treated with Ganciclovir (View Usage). Patient experienced the following unwanted or unexpected effects: bronchospasm, dyspnoea, wheezing. Ganciclovir dosage: 300mg Iv Q12. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), BACTRIM (View Bactrim Review and Bactrim Label ), LANSOPROZOLE (View Lansoprozole Review and Lansoprozole Label ).

6246482-4 | Alternaria Infection, Clostridium Difficile Colitis, Cytomegalovirus Infection, Headache, Hypertension, Metabolic Disorder, Nephropathy Toxic, Papilloma Viral Infection, Renal Impairment
Patient was taking Ganciclovir (View Usage). Patient had the following side effects: alternaria infection, clostridium difficile colitis, cytomegalovirus infection (What is cytomegalovirus infection?), headache (What is headache?), hypertension, metabolic disorder (What is metabolic disorder?), nephropathy toxic, papilloma viral infection, renal impairment on Jun 18, 2009 from UNITED STATES Additional patient health information: Female patient , 41 years of age, was diagnosed with infection prophylaxis, prophylaxis against transplant rejection and. Ganciclovir dosage: . During the same period patient was treated with SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), VALGANCICLOVIR HCL (View Valganciclovir Hcl Review and Valganciclovir Hcl Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), ANTI THYMOCYTE GLOBULIN NOS (View Anti-thymocyte Globulin Nos Review and Anti-thymocyte Globulin Nos Label ), EVEROLIMUS (View Everolimus Review and Everolimus Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ).

6246465-4 | Cytomegalovirus Infection, Diabetes Mellitus, Hyperlipidaemia, Nasopharyngitis, Nephropathy Toxic, Transplant Rejection
Adverse event was reported on Jun 18, 2009 by a Female patient taking Ganciclovir (View Usage) (Dosage: Route: Intravenous) was diagnosed with infection prophylaxis, prophylaxis against transplant rejection and. Location: UNITED STATES , 48 years of age, After Ganciclovir was administered, patient had the following side effects: cytomegalovirus infection (What is cytomegalovirus infection?), diabetes mellitus, hyperlipidaemia, nasopharyngitis, nephropathy toxic, transplant rejection. During the same period patient was treated with SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), PROGRAF (Trough Levels: 12-20 Ng/ml) (View Prograf Review and Prograf Label ), ANTI THYMOCYTE GLOBULIN NOS (View Anti-thymocyte Globulin Nos Review and Anti-thymocyte Globulin Nos Label ).

6241467-6 | Bone Marrow Failure
on Aug 13, 2003 Male patient from BRAZIL , weighting 145.5 lb, was treated with Ganciclovir (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure. Ganciclovir dosage: . During the same period patient was treated with DACLIZUMAB (View Daclizumab Review and Daclizumab Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ). Patient was hospitalized.

6155199-6 | Methaemoglobinaemia, Neutrophil Count Decreased
on Apr 02, 2009 Female patient from UNITED KINGDOM , weighting 159.6 lb, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?), antifungal prophylaxis and was treated with Ganciclovir (View Usage). Patient had the following side effects: methaemoglobinaemia, neutrophil count decreased. Ganciclovir dosage: Unk. During the same period patient was treated with GANCICLOVIR SODIUM (Unk) (View Ganciclovir Sodium Review and Ganciclovir Sodium Label ), DAPSONE (View Dapsone Review and Dapsone Label ), SEPTRIN (View Septrin Review and Septrin Label ). Patient was hospitalized.

6149607-4 | Anaemia, Arthralgia, Cytomegalovirus Enterocolitis, Cytomegalovirus Infection, Erythema Multiforme, Pneumonia Cytomegaloviral
Patient was taking Ganciclovir (View Usage). After Ganciclovir was administered, patient had the following side effects: anaemia, arthralgia, cytomegalovirus enterocolitis, cytomegalovirus infection (What is cytomegalovirus infection?), erythema multiforme, pneumonia cytomegaloviral on Mar 26, 2009 from JAPAN Additional patient health information: Female patient , 21 years of age, weighting 136.7 lb, was diagnosed with prophylaxis against transplant rejection and. Ganciclovir dosage: . During the same period patient was treated with CELLCEPT (View Cellcept Review and Cellcept Label ), RITUXAN (View Rituxan Review and Rituxan Label ), SIMULECT (Route: Injectable (not Otherwise Specified)) (View Simulect Review and Simulect Label ), PROGRAF (Dose Reduced) (View Prograf Review and Prograf Label ), MEDROL (View Medrol Review and Medrol Label ). Patient was hospitalized.

6142992-9 | Clonic Convulsion, Histiocytosis Haematophagic, Juvenile Arthritis
Adverse event was reported on Mar 30, 2009 by a Female patient taking Ganciclovir (View Usage) (Dosage: ) . Location: JAPAN , child 1 years of age, weighting 20.94 lb, Patient experienced the following unwanted or unexpected effects: clonic convulsion, histiocytosis haematophagic, juvenile arthritis. During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ), METHYLPREDNISOLONE 4MG TAB (View Methylprednisolone 4mg Tab Review and Methylprednisolone 4mg Tab Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ). Patient was hospitalized.

6137086-2 | Azotaemia, Complications Of Transplant Surgery, Cytomegalovirus Colitis, Inflammatory Bowel Disease, Weight Decreased
on Mar 23, 2009 Female patient from UNITED STATES , 52 years of age, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?), immunosuppression and was treated with Ganciclovir (View Usage). Patient had the following side effects: azotaemia, complications of transplant surgery, cytomegalovirus colitis, inflammatory bowel disease, weight decreased. Ganciclovir dosage: . During the same period patient was treated with SIROLIMUS (View Sirolimus Review and Sirolimus Label ), TACROLIMUS (Tapered Off) (View Tacrolimus Review and Tacrolimus Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ).

6130084-4 | Abscess, Bone Marrow Failure, Cytomegalovirus Infection, Fungal Infection, Platelet Count Decreased, Red Blood Cell Count Decreased, Respiratory Failure, Staphylococcal Infection, Zygomycosis
on Mar 16, 2009 Male patient from JAPAN , 72 years of age, was treated with Ganciclovir (View Usage). After Ganciclovir was administered, patient had the following side effects: abscess (What is abscess?), bone marrow failure, cytomegalovirus infection (What is cytomegalovirus infection?), fungal infection (What is fungal infection?), platelet count decreased, red blood cell count decreased, respiratory failure, staphylococcal infection (What is staphylococcal infection?), zygomycosis. Ganciclovir dosage: . During the same period patient was treated with FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ). Patient was hospitalized.

6085808-1 | Anaemia, Arthralgia, Cytomegalovirus Enterocolitis, Cytomegalovirus Infection, Erythema Multiforme, Pneumonia Cytomegaloviral
Patient was taking Ganciclovir (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, arthralgia, cytomegalovirus enterocolitis, cytomegalovirus infection (What is cytomegalovirus infection?), erythema multiforme, pneumonia cytomegaloviral on Feb 12, 2009 from JAPAN Additional patient health information: Female patient , 21 years of age, weighting 136.7 lb, was diagnosed with prophylaxis against transplant rejection and. Ganciclovir dosage: . During the same period patient was treated with CELLCEPT (View Cellcept Review and Cellcept Label ), RITUXAN (View Rituxan Review and Rituxan Label ), SIMULECT (Route: Injectable (not Otherwise Specified)) (View Simulect Review and Simulect Label ), PROGRAF (Dose Reduced) (View Prograf Review and Prograf Label ). Patient was hospitalized.

6072473-2 | Aspergillosis, Biliary Tract Disorder, Herpes Oesophagitis, Pneumonia, Renal Failure
Adverse event was reported on Feb 02, 2009 by a Male patient taking Ganciclovir (View Usage) (Dosage: ) was diagnosed with prophylaxis and. Location: UNITED STATES , 58 years of age, Patient had the following side effects: aspergillosis, biliary tract disorder, herpes oesophagitis, pneumonia (What is pneumonia?), renal failure. During the same period patient was treated with MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ).

5991417-2 |
on Dec 03, 2008 Male patient from JAPAN , 40 years of age, weighting 175.5 lb, was treated with Ganciclovir (View Usage). . Ganciclovir dosage: . During the same period patient was treated with SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ). Patient was hospitalized.

5972831-8 |
on Nov 17, 2008 Male patient from JAPAN , 40 years of age, was treated with Ganciclovir (View Usage). . Ganciclovir dosage: . During the same period patient was treated with SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ).

5960249-3 | White Blood Cell Count Decreased
Patient was taking Ganciclovir (View Usage). Patient had the following side effects: white blood cell count decreased on Nov 19, 2008 from UNITED STATES Additional patient health information: Female patient , 64 years of age, weighting 145.5 lb, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and. Ganciclovir dosage: 300 Mg Q12 Hours Iv. During the same period patient was treated with VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), DAPS (View Daps Review and Daps Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), OCTREOTIDE ACETATE (View Octreotide Acetate Review and Octreotide Acetate Label ), LOPERAMIDE HCL (View Loperamide Hcl Review and Loperamide Hcl Label ), COMPAZINE (View Compazine Review and Compazine Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), CODEINE SUL TAB (View Codeine Sul Tab Review and Codeine Sul Tab Label ). Patient was hospitalized.

5960088-3 | Bone Marrow Failure, Mycobacterium Avium Complex Infection
Adverse event was reported on Nov 11, 2008 by a Male patient taking Ganciclovir (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 51 years of age, After Ganciclovir was administered, patient had the following side effects: bone marrow failure, mycobacterium avium complex infection. During the same period patient was treated with VALGANCICLOVIR (View Valganciclovir Review and Valganciclovir Label ), ZITHROMAX (View Zithromax Review and Zithromax Label ), EPIVIR (View Epivir Review and Epivir Label ), PENTAMIDINE (View Pentamidine Review and Pentamidine Label ), ZERIT (View Zerit Review and Zerit Label ), STOCRIN (View Stocrin Review and Stocrin Label ). Patient was hospitalized.

5913636-3 | Castleman's Disease, Multi-organ Failure
on Sep 29, 2008 Male patient from UNITED KINGDOM , 32 years of age, was diagnosed with castleman's disease, hiv infection (What is hiv infection?) and was treated with Ganciclovir (View Usage). Patient experienced the following unwanted or unexpected effects: castleman's disease, multi-organ failure. Ganciclovir dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), KALETRA (Adminstered Daily) (View Kaletra Review and Kaletra Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).

5907872-X | Bronchopulmonary Aspergillosis, Cardiac Failure, Disseminated Cryptococcosis, Renal Failure
on Sep 22, 2008 Female patient from JAPAN , 67 years of age, was treated with Ganciclovir (View Usage). Patient had the following side effects: bronchopulmonary aspergillosis, cardiac failure, disseminated cryptococcosis, renal failure. Ganciclovir dosage: . During the same period patient was treated with MEROPENEM (View Meropenem Review and Meropenem Label ), MICAFUNGIN (View Micafungin Review and Micafungin Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), MIZORIBINE (View Mizoribine Review and Mizoribine Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ).

5885992-6 | Cytomegalovirus Infection, Focal Segmental Glomerulosclerosis, Transplant Rejection
Patient was taking Ganciclovir (View Usage). After Ganciclovir was administered, patient had the following side effects: cytomegalovirus infection (What is cytomegalovirus infection?), focal segmental glomerulosclerosis, transplant rejection on Sep 08, 2008 from UNITED STATES Additional patient health information: Male patient , 51 years of age, was diagnosed with renal transplant, immunosuppression and. Ganciclovir dosage: . During the same period patient was treated with MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), VALGANCICLOVIR HCL (View Valganciclovir Hcl Review and Valganciclovir Hcl Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), THYMOGLOBULIN (In Three Doses.) (View Thymoglobulin Review and Thymoglobulin Label ).

5878839-5 | White Blood Cell Count Decreased
Adverse event was reported on Sep 10, 2008 by a Male patient taking Ganciclovir (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 254.2 lb, Patient experienced the following unwanted or unexpected effects: white blood cell count decreased.

5850990-5 | Cytomegalovirus Infection, Nephropathy Toxic, Transplant Rejection
on Aug 11, 2008 Male patient from JAPAN , 33 years of age, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?), immunosuppression and was treated with Ganciclovir (View Usage). Patient had the following side effects: cytomegalovirus infection (What is cytomegalovirus infection?), nephropathy toxic, transplant rejection. Ganciclovir dosage: . During the same period patient was treated with MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), RITUXIMAB (Units: Mg/mm3) (View Rituximab Review and Rituximab Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), GAMMAGLOBULIN ANTI CMV (View Gammaglobulin Anti Cmv Review and Gammaglobulin Anti Cmv Label ). Patient was hospitalized.

5846552-6 | Bone Marrow Failure
on Aug 04, 2008 Male patient from UNITED STATES , 50 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Ganciclovir (View Usage). After Ganciclovir was administered, patient had the following side effects: bone marrow failure. Ganciclovir dosage: . During the same period patient was treated with ZITHROMAX (View Zithromax Review and Zithromax Label ), EPIVIR (View Epivir Review and Epivir Label ), PENTAMIDINE (View Pentamidine Review and Pentamidine Label ), ZERIT (View Zerit Review and Zerit Label ), STOCRIN (View Stocrin Review and Stocrin Label ), DENOSINE (View Denosine Review and Denosine Label ). Patient was hospitalized.

5761327-4 | Haemoglobinuria, Haemolysis, Intravascular Haemolysis, Transfusion Microchimerism
Patient was taking Ganciclovir (View Usage). Patient experienced the following unwanted or unexpected effects: haemoglobinuria, haemolysis, intravascular haemolysis, transfusion microchimerism on Jun 02, 2008 from AUSTRALIA Additional patient health information: Female patient , child 9 years of age, was diagnosed with prophylaxis and. Ganciclovir dosage: . During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), ANTIBIOTIC NOS (View Antibiotic Nos Review and Antibiotic Nos Label ), SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ).

5713218-2 | Pulmonary Embolism
Adverse event was reported on Aug 18, 1995 by a Male patient taking Ganciclovir (View Usage) (Dosage: ) . Location: UNITED STATES , 47 years of age, Patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with SULFAMETHOXAZOLE (View Sulfamethoxazole Review and Sulfamethoxazole Label ), TRIMETHOPRIM (View Trimethoprim Review and Trimethoprim Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), TESTOSTERONE (View Testosterone Review and Testosterone Label ). Patient was hospitalized.

5648772-2 | Raynaud's Phenomenon
on Aug 26, 2005 Male patient from UNITED KINGDOM , 61 years of age, weighting 171.5 lb, was treated with Ganciclovir (View Usage). After Ganciclovir was administered, patient had the following side effects: raynaud's phenomenon. Ganciclovir dosage: . During the same period patient was treated with VALGANCICLOVIR HCL (View Valganciclovir Hcl Review and Valganciclovir Hcl Label ), NEORAL (View Neoral Review and Neoral Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ).

5523568-0 | Acute Graft Versus Host Disease In Intestine, Cytomegalovirus Antigen Positive, Cytomegalovirus Colitis, Encephalitis Cytomegalovirus, Pancytopenia, Renal Failure Chronic, Sepsis
on Nov 13, 2007 Male patient from UNITED STATES , 46 years of age, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and was treated with Ganciclovir (View Usage). Patient experienced the following unwanted or unexpected effects: acute graft versus host disease in intestine, cytomegalovirus antigen positive, cytomegalovirus colitis, encephalitis cytomegalovirus, pancytopenia, renal failure chronic, sepsis (What is sepsis?). Ganciclovir dosage: Induction. During the same period patient was treated with FOSCARNET (Added On Week 12) (View Foscarnet Review and Foscarnet Label ), CIDOFOVIR (View Cidofovir Review and Cidofovir Label ), LEFLUNOMIDE (View Leflunomide Review and Leflunomide Label ). Patient was hospitalized.

5467575-5 | Endophthalmitis, Hypopyon, Implant Expulsion
Patient was taking Ganciclovir (View Usage). Patient had the following side effects: endophthalmitis, hypopyon, implant expulsion on Sep 06, 2007 from UNITED STATES Additional patient health information: Female patient , 45 years of age, . Ganciclovir dosage: Implant.

5427076-7 | Thrombocytopenia
Adverse event was reported on Aug 24, 2007 by a Female patient taking Ganciclovir (View Usage) (Dosage: 300mg Iv Bid) was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and. Location: UNITED STATES , weighting 132.3 lb, After Ganciclovir was administered, patient had the following side effects: thrombocytopenia. During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), MINOCYCLINE HCL (View Minocycline Hcl Review and Minocycline Hcl Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), CALCIUM (View Calcium Review and Calcium Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), PRANDIN (View Prandin Review and Prandin Label ). Patient was hospitalized.

5333754-0 | Pulmonary Embolism
on May 15, 2007 Female patient from UNITED KINGDOM , 58 years of age, weighting 147.7 lb, was diagnosed with glioma and was treated with Ganciclovir (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary embolism (What is pulmonary embolism?). Ganciclovir dosage: . During the same period patient was treated with CEREPRO (View Cerepro Review and Cerepro Label ). Patient was hospitalized.

5284252-4 | Alanine Aminotransferase Increased, Arthralgia, Aspartate Aminotransferase Increased, Back Pain, Blood Bilirubin Increased, Blood Creatine Phosphokinase Increased, Hepatitis Toxic, Hypersensitivity
on Mar 26, 2007 Male patient from UNITED STATES , 74 years of age, weighting 198.0 lb, was diagnosed with renal transplant, hyperlipidaemia, neuralgia, diabetes mellitus and was treated with Ganciclovir (View Usage). Patient had the following side effects: alanine aminotransferase increased, arthralgia, aspartate aminotransferase increased, back pain (What is back pain?), blood bilirubin increased, blood creatine phosphokinase increased, hepatitis toxic, hypersensitivity. Ganciclovir dosage: . During the same period patient was treated with CYCLOSPORINE (Unk, Unk) (View Cyclosporine Review and Cyclosporine Label ), NIASPAN (500 Mg, Unk) (View Niaspan Review and Niaspan Label ), ZOCOR (400 Mg, Qd) (View Zocor Review and Zocor Label ), LYRICA (View Lyrica Review and Lyrica Label ), NOVOLOG (Sliding Scale, Prn) (View Novolog Review and Novolog Label ), LANTUS (16 U, Qd) (View Lantus Review and Lantus Label ), MYFORTIC (View Myfortic Review and Myfortic Label ). Patient was hospitalized.

5257167-5 | Cognitive Disorder, Hyperthermia, Hypophosphataemia
Patient was taking Ganciclovir (View Usage). After Ganciclovir was administered, patient had the following side effects: cognitive disorder, hyperthermia, hypophosphataemia on Feb 27, 2007 from UNITED KINGDOM Additional patient health information: Male patient , 69 years of age, weighting 136.7 lb, was diagnosed with glioma and. Ganciclovir dosage: . During the same period patient was treated with CEREPRO (View Cerepro Review and Cerepro Label ), SOLUPRED (View Solupred Review and Solupred Label ). Patient was hospitalized.

5257167-5 | Cognitive Disorder, Hyperthermia, Hypophosphataemia
Adverse event was reported on Feb 27, 2007 by a Male patient taking Ganciclovir (View Usage) (Dosage: ) was diagnosed with glioma and. Location: UNITED KINGDOM , 69 years of age, weighting 136.7 lb, Patient experienced the following unwanted or unexpected effects: cognitive disorder, hyperthermia, hypophosphataemia. During the same period patient was treated with CEREPRO (View Cerepro Review and Cerepro Label ), SOLUPRED (View Solupred Review and Solupred Label ). Patient was hospitalized.

5238293-3 | Alanine Aminotransferase Increased, Arthralgia, Aspartate Aminotransferase Increased, Back Pain, Blood Creatine Phosphokinase Increased, Hepatitis Toxic, Hypersensitivity, Muscle Spasms
on Feb 05, 2007 Male patient from UNITED STATES , 74 years of age, was diagnosed with renal transplant, hyperlipidaemia, neuralgia and was treated with Ganciclovir (View Usage). Patient had the following side effects: alanine aminotransferase increased, arthralgia, aspartate aminotransferase increased, back pain (What is back pain?), blood creatine phosphokinase increased, hepatitis toxic, hypersensitivity, muscle spasms. Ganciclovir dosage: . During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), NIASPAN (500 Mg, Unk) (View Niaspan Review and Niaspan Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LYRICA (View Lyrica Review and Lyrica Label ). Patient was hospitalized.

5144226-0 | Bone Marrow Failure, Influenza Like Illness, Neutrophil Morphology Abnormal, Respiratory Disorder
on Oct 25, 2006 Male patient from UNITED KINGDOM , 42 years of age, was treated with Ganciclovir (View Usage). After Ganciclovir was administered, patient had the following side effects: bone marrow failure, influenza like illness, neutrophil morphology abnormal, respiratory disorder. Ganciclovir dosage: Dose = 44mg/kg/day. During the same period patient was treated with GANCICLOVIR SODIUM (Taken For 4 Weeks) (View Ganciclovir Sodium Review and Ganciclovir Sodium Label ), VALGANCICLOVIR HCL (Dose = 15 Mg/kg/day) (View Valganciclovir Hcl Review and Valganciclovir Hcl Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), CO TRIMOXAZOLE (View Co-trimoxazole Review and Co-trimoxazole Label ).

5117580-3 | Hepatitis
Patient was taking Ganciclovir (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis (What is hepatitis?) on Sep 19, 2006 from FRANCE Additional patient health information: Female patient , 53 years of age, . Ganciclovir dosage: . During the same period patient was treated with ARGININE BUTYRATE (View Arginine Butyrate Review and Arginine Butyrate Label ), ADRIAMYCIN PFS (The Patient Received Four Cycles Of Treatment In Combination With Cyclophosphamide/bleomycin And Pr+) (View Adriamycin Pfs Review and Adriamycin Pfs Label ), CYCLOPHOSPHAMIDE (The Patient Received Four Cycles Of Treatment In Combination With Adriamycin, Bleomycin And Prednis+) (View Cyclophosphamide Review and Cyclophosphamide Label ), BLEOMYCIN (The Patient Received Four Cycles Of Treatment In Combination With Adriamycin, Cyclophosphamide And +) (View Bleomycin Review and Bleomycin Label ), PREDNISONE TAB (The Patient Received Four Cycles Of Treatment In Combination With Adriamycin, Cyclophosphamide And +) (View Prednisone Tab Review and Prednisone Tab Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ).

5034340-2 | Herpes Zoster
Adverse event was reported on Mar 31, 2006 by a Female patient taking Ganciclovir (View Usage) (Dosage: ) . Location: JAPAN , 29 years of age, Patient had the following side effects: herpes zoster.

4970832-X | Granulocytopenia, Herpes Zoster
on Mar 31, 2006 Female patient from JAPAN , 29 years of age, was treated with Ganciclovir (View Usage). After Ganciclovir was administered, patient had the following side effects: granulocytopenia, herpes zoster. Ganciclovir dosage: .

4969038-X | Agranulocytosis, Herpes Zoster
on Mar 22, 2006 Female patient from UNITED STATES , 29 years of age, was treated with Ganciclovir (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis, herpes zoster. Ganciclovir dosage: Intravenous.

4889480-5 | Talipes
Patient was taking Ganciclovir (View Usage). Patient had the following side effects: talipes on Jan 09, 2006 from UNITED KINGDOM Additional patient health information: Female patient , 37 years of age, was diagnosed with analgesic effect and. Ganciclovir dosage: 250 Mg, Bid. During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), PARACETAMOL (1 G, Qid Prn) (View Paracetamol Review and Paracetamol Label ), CODEINE PHOSPHATE (60 Mg, Bid Prn) (View Codeine Phosphate Review and Codeine Phosphate Label ), PREDNISOLONE (40mg Daily) (View Prednisolone Review and Prednisolone Label ), CYCLOSPORINE (125 Mg, Bid) (View Cyclosporine Review and Cyclosporine Label ), BUPIVACAINE (View Bupivacaine Review and Bupivacaine Label ), HYDROCORTISONE (100 Mg, Qid) (View Hydrocortisone Review and Hydrocortisone Label ).